Researchers are excited about the medication , a groundbreaking dual treatment showing promising results in early trials for size loss . It functions by targeting both systems: GLP-1 and GIP, which , https://harmonytcud406435.ziblogs.com/41084274/this-new-hope-for-body-reduction